Using Lipoglycopeptides
Long-Acting Lipoglycopeptides for Skin and Soft Tissue Infections: Implementation Into Practice

Released: August 08, 2023

Kyle Molina
Kyle Molina, PharmD, BCIDP

Activity

Progress
1
Course Completed

In this episode, Kyle Molina, PharmD, BCIDP, discusses key considerations for successful implementation of long-acting lipoglycopeptides into clinical practice. Listen as he gives perspectives on:

  • Reasons to consider use of long-acting lipoglycopeptides (eg, poor adherence to oral antibiotics, PICC-related costs and complications)
  • Data supporting and challenging cost effectiveness of long-acting lipoglycopeptides
  • Identifying the target patient population
  • Selecting the right location to provide long-acting lipoglycopeptides
  • Strategies to maximize institutional impact with key stakeholders (eg, hospital avoidance, reduced ED and hospital length of stay)
  • Key characteristics of available long-acting lipoglycopeptides
  • Addressing logistical challenges, including navigating the reimbursement process